- Home
- DCTH vs CTO Comparison
DCTH vs CTO Comparison
Compare DCTH & CTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- CTO
- Stock Information
- Founded
- DCTH 1988
- CTO 1902
- Country
- DCTH United States
- CTO United States
- Employees
- DCTH N/A
- CTO N/A
- Industry
- DCTH Medical/Dental Instruments
- CTO Real Estate Investment Trusts
- Sector
- DCTH Health Care
- CTO Real Estate
- Exchange
- DCTH Nasdaq
- CTO Nasdaq
- Market Cap
- DCTH 630.4M
- CTO 589.6M
- IPO Year
- DCTH N/A
- CTO N/A
- Fundamental
- Price
- DCTH $16.21
- CTO $18.44
- Analyst Decision
- DCTH Strong Buy
- CTO Strong Buy
- Analyst Count
- DCTH 4
- CTO 3
- Target Price
- DCTH $24.00
- CTO $22.33
- AVG Volume (30 Days)
- DCTH 610.5K
- CTO 217.7K
- Earning Date
- DCTH 05-08-2025
- CTO 07-24-2025
- Dividend Yield
- DCTH N/A
- CTO 8.25%
- EPS Growth
- DCTH N/A
- CTO N/A
- EPS
- DCTH N/A
- CTO N/A
- Revenue
- DCTH $53,850,000.00
- CTO $132,203,000.00
- Revenue This Year
- DCTH $141.47
- CTO $19.25
- Revenue Next Year
- DCTH $49.31
- CTO $8.47
- P/E Ratio
- DCTH N/A
- CTO N/A
- Revenue Growth
- DCTH 1068.87
- CTO 17.48
- 52 Week Low
- DCTH $6.33
- CTO $16.12
- 52 Week High
- DCTH $18.23
- CTO $21.15
- Technical
- Relative Strength Index (RSI)
- DCTH 58.15
- CTO 56.02
- Support Level
- DCTH $16.02
- CTO $17.46
- Resistance Level
- DCTH $17.29
- CTO $18.35
- Average True Range (ATR)
- DCTH 0.99
- CTO 0.31
- MACD
- DCTH -0.03
- CTO 0.06
- Stochastic Oscillator
- DCTH 49.63
- CTO 87.11
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
About CTO CTO Realty Growth Inc.
CTO Realty Growth Inc is a real estate investment trust company, that owns income properties comprised of approximately 2.7 million square feet in diversified markets in the United States. Its portfolio of assets consists of Income Properties Portfolio, management services, Commercial Loan and Investments.